Literature DB >> 1521887

Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature.

A Kaufhold1, R R Reinert, W Kern.   

Abstract

During a three-year period eight patients with blood cultures positive for Stomatococcus mucilaginosus were identified at two university hospitals. One patient without any signs of infection had a central venous catheter that was colonized with this organism, two patients had transient bacteremia without definite relationship to underlying disease, whereas the remaining five patients suffered from clinically significant infections. Of these last five patients, one had undergone prior head and neck surgery and four had hematologic malignancy with mild to severe neutropenia; two of the latter patients developed the infection subsequent to dental surgery. Besides neutropenia and mucosal damage in the oropharynx, quinolone antibacterial prophylaxis may have been an additional risk factor for the development of S. mucilaginosus bacteremia in these patients. A thorough review of the literature revealed that in addition to our findings, endocarditis and foreign body infections are further typical clinical manifestations. Although the overall antibiotic susceptibility pattern of S. mucilaginosus resembles that of streptococci, it is suggested that penicillin G may not be the drug of choice for initial therapy of particularly severe infections. S. mucilaginosus can be easily differentiated from other gram-positive bacteria when certain key criteria (e.g. adherence to agar surfaces, poor growth on Mueller-Hinton agar, presence of a capsule) as well as an array of biochemical tests, including commercially available identification systems, are applied. Our own and published data emphasize that both microbiologists and clinicians should be increasingly aware of this opportunistic pathogen.

Entities:  

Mesh:

Year:  1992        PMID: 1521887     DOI: 10.1007/bf02033062

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  28 in total

1.  Stomatococcus mucilaginosus infections in children with leukemia.

Authors:  M E Weinblatt; I Sahdev; M Berman
Journal:  Pediatr Infect Dis J       Date:  1990-09       Impact factor: 2.129

2.  Stomatococcus mucilaginosus catheter-related infection in an adolescent with osteosarcoma.

Authors:  D P Ascher; M C Bash; C Zbick; C White
Journal:  South Med J       Date:  1991-03       Impact factor: 0.954

3.  [Sensitivity to antibiotics of 64 strains of Stomatococcus mucilaginosus isolated in human clinical cases. Demonstration of erythromycin resistance].

Authors:  A Rochette; M Chomarat; M de Montclos
Journal:  Pathol Biol (Paris)       Date:  1988-05

4.  [Antibiotic sensitivity of 32 strains of Stomatococcus mucilaginosus in oral medicine patients in community practice].

Authors:  M Chomarat; C Martin; F Breysse
Journal:  Pathol Biol (Paris)       Date:  1989-05

5.  Stomatococcus mucilaginosus prosthetic valve endocarditis.

Authors:  H L Lazar; C Sulis; W Hauser
Journal:  J Thorac Cardiovasc Surg       Date:  1988-05       Impact factor: 5.209

6.  Stomatococcus mucilaginosus endocarditis in an intravenous drug abuser.

Authors:  D A Relman; K Ruoff; M J Ferraro
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

7.  Stomatococcus mucilaginosus bacteremias. Typical case presentations, simplified diagnostic criteria, and a literature review.

Authors:  P S Mitchell; B J Huston; R N Jones; L Holcomb; F P Koontz
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Nov-Dec       Impact factor: 2.803

8.  Bacteraemia caused by Stomatococcus mucilaginosus in a granulocytopenic patient with acute lymphocytic leukaemia.

Authors:  G Weers-Pothoff; I R Novakova; J P Donnelly; H L Muytjens
Journal:  Neth J Med       Date:  1989-10       Impact factor: 1.422

9.  Stomatococcus mucilaginosus endocarditis.

Authors:  J Prag; E Kjøller; F Espersen
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

10.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

View more
  5 in total

1.  Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Authors:  Poornima Ramanan; Jason N Barreto; Douglas R Osmon; Pritish K Tosh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

2.  Association of Stomatococcus mucilaginosus with cholangitis.

Authors:  V P Harjola; M Valtonen; A Sivonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

3.  Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.

Authors:  F H van Tiel; B F Slangen; H C Schouten; J A Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

4.  Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.

Authors:  C von Eiff; M Herrmann; G Peters
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia.

Authors:  M Treviño; A García-Zabarte; A Quintás; E Varela; J M López-Paz; A Jato; C García-Riestra; B J Regueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.